Under construction – not a live service
Sign in
Taking people in MexicoNo phase

Registry tracking outcomes of electroporation treatment for pancreatic cancer

Collects information on irreversible electroporation for unresectable pancreatic tumors in adults.

Plain-language title generated from the registry record
Registry title: American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry

Key facts

Where
Mexico City, MexicoSee the site

Where in Mexico

  • Centro MedicoMexico City, MexicoTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Louisville
Trial code
NCT02674100
Record updated
25 February 2025
Original description
The purpose of this study is to create a registry to provide insight into treatment selection and treatment outcome of pancreatic IRE in order to develop an evidence base such that physicians can provide the best possible care to patients with pancreatic cancer requiring surgical interventions.Read full original descriptionShow less

AHPBA Pancreatic Irreversible Electroporation (IRE) Registry for Pancreatic Cancer

The purpose of this study is to create a registry to provide insight into treatment selection and treatment outcome of pancreatic IRE in order to develop an evidence base such that physicians can provide the best possible care to patients with pancreatic cancer requiring surgical interventions.

The investigators seek a better understanding of the uses of ablation in the treatment of unresectable soft tissue pancreatic tumors and the limitations, concerns and complications that earlier users have.

Inclusion: Adult patients (greater than 18 years of age) diagnosed with pancreatic cancer that are eligible for soft tissue ablation per the treating physician.

Exclusion: Non-removable implants with metal parts near target lesion; Myocardial infarction within 3 months prior to enrollment; Have a cardiac pacemaker or ICD implant; Not suitable for general endotracheal anesthesia.

ClinicalTrials.gov NCT02674100